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ARTICLE
Toll-like receptor 2 expression on c-kit+ cells
tracks the emergence of embryonic deﬁnitive
hematopoietic progenitors
Jana Balounová1,2,11, Iva Šplíchalová1,3,11, Martina Dobešová1, Michal Kolář4, Karel Fišer 5, Jan Procházka2,
Radislav Sedlacek2, Andrea Jurisicova6, Hoon-ki Sung7, Vladimír Kořínek8, Meritxell Alberich-Jorda9,
Isabelle Godin 10 & Dominik Filipp 1*
Hematopoiesis in mammalian embryos proceeds through three successive waves of hema-
topoietic progenitors. Since their emergence spatially and temporally overlap and phenotypic
markers are often shared, the speciﬁcs regarding their origin, development, lineage restriction
and mutual relationships have not been fully determined. The identiﬁcation of wave-speciﬁc
markers would aid to resolve these uncertainties. Here, we show that toll-like receptors
(TLRs) are expressed during early mouse embryogenesis. We provide phenotypic and
functional evidence that the expression of TLR2 on E7.5 c-kit+ cells marks the emergence of
precursors of erythro-myeloid progenitors (EMPs) and provides resolution for separate
tracking of EMPs from primitive progenitors. Using in vivo fate mapping, we show that at E8.5
the Tlr2 locus is already active in emerging EMPs and in progenitors of adult hematopoietic
stem cells (HSC). Together, this data demonstrates that the activation of the Tlr2 locus tracks
the earliest events in the process of EMP and HSC speciﬁcation.
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Mammalian hematopoiesis proceeds through three suc-cessive waves of progenitors. The ﬁrst, referred to as theprimitive wave, arises in the yolk sac (YS) at E7.25 and
consists of progenitors of primitive nucleated erythrocytes (EryP)
and megakaryocytes (Mk)1–3. Monopotent progenitors of mac-
rophages (MFs) are also considered to be part of this wave4,5. At
E8.5, a second, transient deﬁnitive wave of erythro-myeloid
progenitors (EMPs) and lympho-myeloid progenitors (LMPs)
emerges from the YS hemogenic endothelium (HE)6–8. Ulti-
mately, around E10.5, hematopoietic stem cells (HSCs) emerge
from the HE of the ventral ﬂoor of the dorsal aorta in the
aorta–gonad–mesonephros region (AGM)9,10. Commencing
from E9.5, EMPs from YS and other hemogenic tissues11 and at
E10.5 HSCs from AGM, start to seed and expand in the forming
fetal liver (FL). Subsequently, these progenitors migrate and dif-
ferentiate to tissue-resident MFs, with the latter populating the
bone marrow (BM), spleen, or thymus4,6,12–14.
Hematopoietic commitment in YS and AGM occurs inde-
pendently of each other via the endothelial to hematopoietic
transition (EHT) of Runx1 expressing cells, and is traceable by the
appearance of CD41 on the surface of c-kit+ cells8,15–17. Due to
differences in the timing of their appearance, lineage potential
and combinatorial dependency on developmental factors, such as
Runx1, c-myb, and Notch, the progenitors of the primitive ery-
thropoiesis are considered to be distinct from EMPs and HSCs
which exhibit deﬁnitive hematopoietic potential18. This is in
agreement with the observation that primitive erythropoiesis
occurs in Runx1 deﬁcient embryos, although EMPs, HSCs, and
also MFs are absent8,19,20. However, other studies have suggested
that these hematopoietic waves not only share their progenitors
but also phenotypic markers, such as c-kit and CD413,8,21. Due to
low temporal resolution, lineage-tracing experiments that employ
Tie2, Runx1, and c-Kit reporters have failed to track the separate
emergence of primitive versus EMP-derived MFs22–24. Thus,
identiﬁcation of additional surface markers would be vital in
revealing the developmental and functional relationship between
hematopoietic waves.
Toll-like receptors (TLRs) recognize various structures of
microbes and are crucial for triggering immune responses to
infections25,26. TLR stimulation of adult BM HSCs during
infection redirects BM hematopoiesis toward the increased pro-
duction of myeloid cells, demonstrating their role in hemato-
poietic homeostasis under inﬂammatory conditions27–29. So far,
only a few studies have analyzed the expression of TLRs in
embryonic development30–32, leaving the ontogeny of TLR
expression in pre-circulation embryos unknown.
We show here that TLR2 is expressed on E7.5 c-kit+ YS cells,
which co-express the hematopoietic emergence markers Runx1
and CD41 and exhibit the functional attributes of EMPs. In
addition, E8.5 TLR2+ c-kit+ EMPs respond to TLR2 stimulation
in a MyD88-dependent manner. By genetic labeling of progeni-
tors with active Tlr2-regulatory elements, we have determined
their contribution to deﬁnitive hematopoietic lineages. Alto-
gether, co-expression of TLR2 and c-kit serves as a reliable
marker to track the emergence of EMPs and HSCs as well as the
tracing of their origin, emergence, fate, lineage potential, and
function.
Results
E7.5 YS-derived TLR2+c-kit+ cells are emerging precursors of
EMPs. We have previously shown that TLRs are expressed in
E10.5 YS-derived MFs33. After deeper analysis, we detected the
transcripts of Tlrs and their adaptors already at E7.5 (Supple-
mentary Fig. 1a). At this time point, TLR protein expression,
exempliﬁed by TLR2, showed a scattered pattern of distribution
across the YS. Anatomically, TLR2LOW cells were most abundant
in the YS and posterior primitive streak (PPS), where cells
undergo epithelial to mesenchymal transition (Fig. 1a; Supple-
mentary Movie 1).
The localization of TLR2+ cells within the PPS and YS suggests
an association with early hematopoiesis. To focus exclusively on
embryonically derived cells, we used crosses between wild-type
(Actbwt/wt) and actin-βEGFP (ActbEGFP/wt) transgenic mice to
distinguish cells of maternal and embryonic origin based on their
EGFP expression (Supplementary Fig. 1b). This data conﬁrmed
that maternal MFs at ~E8.5–9.5 are replaced by embryo-derived
ones5 and that TLR2+CD11b–CD45– cells, already present at
E7.5, are indeed of embryonic origin.
At E7.5, a large proportion of embryonic ActbEGFPTLR2+CD45–
cells also co-expressed c-kit, a hallmark of hematopoietic
progenitors. TLR2+c-kit+ cells were largely restricted to YS, with
signiﬁcantly lower numbers in the embryo proper (EP) (Fig. 1b).
Importantly, only TLR2+c-kit+ cells from YS, but not those from
EP, were positive for the early hematopoietic marker, CD413
(Fig. 1c). Similarly, TLR2+c-kit+ progenitors isolated from YS,
but not EP, expressed mRNA encoding Runx1, an obligatory
transcription factor (TF) required for the emergence of deﬁnitive
hematopoiesis (Fig. 1d). Runx1 was also expressed by the YS-
derived TLR2–c-kit+ population, which was also positive for CD41
(Fig. 1c). This is consistent with the emergence of hematopoietic
progenitors exclusively among c-kit+ cells in the YS8.
Next, we tested whether the expression of TLR2 on E7.5 c-kit+
cells marks progenitors with an early commitment to a
hematopoietic fate. Using ActbEGFP embryos, we gated on YS-
derived embryonic TLR2+ or TLR2– cells and analyzed the
kinetics of their c-kit and CD45 expression. At E7.5, TLR2+ cells
separated into two subsets: one expressing high levels of c-kit
while the other was c-kit– (Fig. 1e, top panels). During the
speciﬁcation of the TLR2+ subset toward the CD45+ cells, we
observed three stages: (i) at E8.5, the c-kit– subset increased its c-
kit expression with virtually all TLR2+ cells becoming c-kit+; (ii)
at E9.75, TLR2+c-kit+CD45– cells acquired CD45 surface
expression; and (iii) concomitantly downregulated c-kit. In
contrast, the TLR2– phenotype was associated with low/negative
c-kit expression. However, despite the upregulation of c-kit
expression in some cells at E8.5–9.5, the entire TLR2– subset
remained CD45 negative (Fig. 1e, bottom panels).
Consistent with the observed transition to hematopoietic fate,
TLR2+c-kit+ cells expressed higher levels of endothelial,
hematopoietic, and myeloid markers as well as TFs typical for
EHT in comparison with the TLR2–c-kit+ subset (Supplementary
Fig. 1c, d). During their maturation toward the CD45+ stage, the
expression of myeloid markers increased while endothelial
markers such as Tie2 and Cd31 were downregulated, a distinctive
feature of EHT. It is of note, that Gata1, a TF required for the
generation of primitive erythroblasts34, was the only gene which
was preferentially expressed in TLR2–c-kit+ cells (Supplementary
Fig. 1d). These data imply that in E7.5–10.5 YS, the process of
hematopoietic maturation toward CD45+ stage is restricted to
TLR2+c-kit+ progenitors.
To establish if the developmental progression of E7.5 TLR2+c-
kit+ progenitors is cell autonomous, we assessed their hemato-
poietic potential in a clonogenic assay at days 5 and 12 (Fig. 1f;
Supplementary Fig. 2a, b). After 5 days of culture, only c-kit+ cells
gave rise to visible colonies with those derived from TLR2+c-kit+
cells being more abundant. Importantly, erythroid colonies from
E7.5 TLR2–c-kit+ progenitors expressed signiﬁcantly higher ratio
between embryonic and adult globins than their TLR2+c-kit+
counterparts (Supplementary Fig. 2b). When scored at 12 days of
culture, both c-kit+ subsets produced erythroid and megakar-
yocytic colonies (E/Mk). However, a critical distinction between
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TLR2–c-kit+ and TLR2+c-kit+ progenitors was that only the
latter gave rise to mixed colonies (Mix) (Fig. 1f; Supplementary
Fig. 2b). In ﬁve independent experiments, apart from the
occasional monopotent myeloid colonies (G/M), mixed colonies
from TLR2–c-kit+ progenitors were never observed. This
principal distinction of EMPs, signiﬁed by TLR2 expression on
their c-kit+ precursors, was functionally discernable despite the
fact that a fraction of both TLR2+c-kit+, and to a lesser extent,
TLR2–c-kit+ subsets, co-expressed Tie2, CD31 along with CD41
(Fig. 1g; Supplementary Fig 2c, middle row), suggesting their
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common hemogenic endothelial ancestry and hematopoietic fate.
However, while t-SNE analysis revealed that these two subsets
displayed a continuum of Tie2, CD31, and CD41 surface
expression, it was the TLR2+c-kit+ subset which formed a tight
cluster (red dots) with the highest expression of these markers
(Supplementary Fig. 2c, bottom panel). Taken together, the
expression of TFs, endothelial, and hematopoietic markers and
the outcome from clonogenic assay link TLR2–c-kit+ progenitors
to primitive erythro/megakaryopoiesis. In contrast, TLR2 expres-
sion on E7.5 c-kit+ YS progenitors accompanied by the high
expression of Tie2, CD31 and CD41 predicates the acquisition of
functional competence for multi-lineage EMP potential. Thus,
TLR2 expression allows for the unequivocal distinction of
emerging precursors of EMPs among coexisting progenitors of
primitive erythropoiesis.
TLR2 stimulation of TLR2+c-kit+ precursors enhances the
production of myeloid cells. When E8.5 ActbEGFP+ cells of
either TLR2+c-kit+, TLR2–c-kit+, or TLR2–c-kit– phenotypes
were co-cultured with OP-9 stroma in the presence or absence of
the TLR2 agonist, Pam3CSK4, both TLR2– populations failed to
survive. However, ~39 and 24% of ActbEGFP+ cells that were
either stimulated or not stimulated with Pam3CSK4, respectively,
were recovered from co-cultures with TLR2+c-kit+ progenitors
(Fig. 1h). The increased survival after TLR2 stimulation corre-
lated with a higher rate of proliferation that was fully dependent
on MyD88, the adaptor protein which is required for
TLR2 signaling (Fig. 1i; Supplementary Fig. 2d). In addition,
Pam3CSK4-stimulated cells showed a more efﬁcient myeloid
differentiation rate measured by the expression of CD11b
(Fig. 1j). This data, as well as the ﬁndings of a previous report,
suggest that the capacity of activated TLRs to nudge the output of
hematopoiesis toward myelo/granulopoiesis is inherent to all
progenitors of deﬁnitive hematopoiesis, ontogenetically com-
mencing with the emergence of TLR2+c-kit+ precursors of
EMPs29.
Tlr2 locus is efﬁciently activated in erythro-myeloid progeni-
tors. To follow the fate of cells with an active Tlr2 locus, we
generated a Tlr2Cre mouse strain by BAC recombineering. In
adult animals, Tlr2 activation labeled all hematopoietic lineages
and their progenitors with no signiﬁcant bias (Supplementary
Fig. 3). To determine the ﬁrst ontogenetic time point of Tlr2-
driven labeling, we looked at the emergence of Tlr2CreEYFP+ cells
in E7.5–E10.5 embryos. Due to the expected delay caused by Cre-
mediated recombination followed by EYFP labeling, the ﬁrst
Tlr2CreEYFP+ cells appeared at E8.5 (0–8sp) (Fig. 2).
If TLR2 expression marks the emergence of EMP precursors,
then EMPs and their progeny with a sufﬁciently activated Tlr2
promoter should be genetically labeled in the Tlr2-driven reporter
mice. Thus, we ﬁrst assessed the phenotype and frequency of
labeled cells by combining Ter119, c-kit, CD41, and FcRγ surface
markers to discriminate erythroid and myeloid precursors6. The
analysis of Tlr2CreEYFP+ cells at E8.5, E9.5 YS, and EP revealed the
presence of ﬁve distinct populations that represented the most
abundant Tlr2CreEYFP+ subsets (Supplementary Fig. 4a). At E8.5,
Tlr2CreEYFP+ cells accounted for an average 6.9% of the total cells,
among which non-hematopoietic cells and primitive erythrocytes
(EryP) each represented ~40%. Subsets of c-kit+FcRγ+ (MFp), c-kit
+CD41+ (Mkp), and c-kit+CD41+FcRγ+ (EMPs) phenotypes
Fig. 1 Early YS-derived TLR2+ c-kit+ cells exhibit features of EMP precursors. a Immunoﬂuorescence of E7.5 embryos revealed the presence of TLR2+ cells
(green) predominantly in YS. Weaker TLR2 staining was also detected in PPS (white insert). Nuclei were stained with DAPI (blue). YS yolk sac, EP embryo
proper, PPS posterior primitive streak. A representative image is shown (n= 2 independent experiments with at least four embryos per experiment).
b–j ActbEGFP/wt embryos (see Supplementary Fig. 1b) were used to analyze cells of embryonic origin. b Quantiﬁcation of ActbEGFP+CD45–c-kit+TLR2+ cells
in E7.5 EP and YS (mean ± SD; n= 6; **p≤ 0.01, ***p≤ 0.001; paired, two-tailed t test). c Surface co-expression of TLR2 with CD41 determined on E7.5
ActbEGFP+CD45–c-kit+ cells obtained from EP or YS. d Runx1 mRNA expression normalized to Gapdh levels in four sorted subsets of E7.5 embryonic
ActbEGFP+CD45– cells with combinatorial expression of c-kit and TLR2 (mean ± SD; n= 3; *p≤ 0.05, **p≤ 0.01; paired, two-tailed t test). e E7.5- E10.5 YS
ActbEGFP+ cells of either TLR2+ or TLR2– phenotype were analyzed for the expression of c-kit and CD45 by FCM. f E7.5 ActbEGFP+Lin− cells (Lin=
CD3–Gr-1–CD11b–B220–Ter119–) were sorted based on their c-kit and TLR2 expression (see sorting strategy in Supplementary Fig. 2a), plated in a
methylcellulose medium M3434 (StemCell Technologies) and assessed for their CFU potential (mean ± SEM; n= 5). g YS-derived E7.5 ActbEGFP+Ter119–
CD45–c-kit+TLR2+ cells were analyzed for Tie2, CD41, and CD31 expression. See full gating strategy in Supplementary Fig. 2c. h–j Sorted E8.5 ActbEGFP+
cells were plated on OP-9 stromal cells in the presence or absence of the TLR2 agonist Pam3CSK4 (1 μg/ml) and analyzed by FCM after 72 h (n= 3).
h Survival analysis of sorted E8.5 TLR2+/–c-kit+/–CD45–cells. i The proliferation history of E8.5 TLR2+c-kit+CD45– cells sorted from MyD88+/+ or
MyD88–/– embryos was assessed by the dilution of a proliferation dye in TLR2+ cells (see also Supplementary Fig. 2d). j ActbEGFP+ cells recovered from
cultures of ActbEGFP+TLR2+ c-kit+ CD45– cells stimulated, or unstimulated, with Pam3CSK4 were analyzed for CD11b and TLR2 expression. Source data are
provided as a Source Data ﬁle
E8.5
(0–8sp)
TIr2Cre Rosa26EYFP
E9.5
(16–24sp)
E10.5
(30–34sp)
Fig. 2 Lineage tracing shows early activation of Tlr2 locus in hematopoietic
progenitors. Spatial microscopic analysis of E8.5–E10.5 Tlr2CreEYFP+ cells;
scale bar= 1 mm. Representative image is shown (n= 3 independent
experiments with 3–6 embryos per experiment)
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collectively represented the remaining ∼20% of Tlr2CreEYFP+
cells (Supplementary Fig. 4a). While being at E8.5 the least
frequent population among Tlr2CreEYFP+ subsets, YS EMPs,
which expressed the highest levels of c-kit, exhibited the highest
labeling efﬁciency (∼60%, Fig. 3a, top scatterplot) attesting to the
preferential and robust activation of their Tlr2 locus. Other
populations, Mkp, MFp, and by E9.5 also CD41+ Mk, were also
preferentially labeled well above the average recombination
probability (arp) threshold. In contrast, EryPs were negligibly
labeled (Fig. 3a, scatterplots). In the E9.5 YS, due to their
expansion, EMPs accounted for 17–38% of all Tlr2CreEYFP+ cells
with even higher labeling efﬁciency (< 80%) (Supplementary
Fig. 4a and Fig. 3a, middle scatterplots). Consistent with previous
reports, at E9.5, only a fraction of TLR2+ EMPs were found in EP
compared to YS (Supplementary Fig. 4b) conﬁrming that these
cells emerge in YS4,35.
Interestingly, when maternally-derived FcRγ+ MFs (mMFs)
were discounted, nearly one-half of the minute population of E8.5
FcRγ+ cells (eFcγ) was also Tlr2-labeled (Supplementary Fig. 4c).
However, as these cells, in contrast to mMFs (Supplementary
Fig. 1b, right panel), were virtually all CD45–CD11b– (Supple-
mentary Fig. 4c) they could not be considered bona-ﬁde MFs.
Moreover, since they represented merely 0.3% of all Tlr2- labeled
cells, it is impossible at this junction to make any statement about
their origin and afﬁliation to a certain hematopoietic wave and
lineage. However, Tlr2CreEYFP+ tissue-resident MFs were
microscopically detectable in the E11.5 head and FL (Supple-
mentary Fig. 4d). In addition, and consistent with the activation
of Tlr2 locus in the progenitors of EMPs, while E11.5 FL early
erythroid progenitors (Early E)36 were labeled almost as
efﬁciently as FL and circulating EMPs, circulating and FL EryPs
were labeled with only background and sub-background
frequencies, respectively (Supplementary Fig. 4e, f).
Functionally, Tlr2CreEYFP+Lin– cells isolated from E8.5
(0–8sp) embryos (Supplementary Fig. 4g) exhibited the potential
to generate erythroid, myeloid, and mixed colonies (Fig. 3b). In
addition, E8.5 Tlr2CreEYFP+Lin– cells responded to TLR2
triggering by an enhanced proliferation rate (Fig. 3c). Thus, the
expression of functional TLR2 accompanies the emergence of
EMPs in vivo.
E8.5 Tlr2-labeled progenitors contribute to embryonic hema-
topoiesis. To follow the developmental fate of cells with active
Tlr2 locus in a time controlled manner, we generated a
Tlr2CreERT2 mouse BAC strain (Supplementary Fig. 5a). In this
model, Cre expression and the generation of EYFP+ cells was
a
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accomplished within 18 h upon 4-hydroxy tamoxifen (4-OHT)
administration (Supplementary Fig. 5b). The ﬁrst Tlr2CreER-
T2Rosa26EYFP recombined embryos were found when 4-OHT
was applied at E7.75 (Fig. 4a, b), resulting in the appearance of
labeled cells in the FL and thymus (FT) (Fig. 4c). A single
4-OHT pulse at E7.75, E8.5, E9.5, or E10.5 marked hemato-
poietic progenitors that in E17.5 FL and FT gave rise to
all main hematopoietic lineages (Fig. 4d; Supplementary
Fig. 5c) with the highest labeling efﬁciencies at E8.5 and
E9.5 (Fig. 4c). Moreover, consistent with the initiation of
TLR2 expression in the precursors of EMPs at E7.5,
when pulsed at E7.75, myeloid cells, including Ly6G+
granulocytes and Ly6C+ monocytes, were labeled in E13.5
Tlr2CreERT2Rosa26tdTomato FL (Fig. 5e; Supplementary Fig. 5d),
supportive evidence of their early EMP origin. It is of note, that
in the absence of 4-OHT, no labeling was observed (Supple-
mentary Fig. 5e). This data conﬁrm that the E7.75 embryo
already contains a fully committed pool of multi-lineage
progenitors of EMP and LMP.
We next investigated the fate of Tlr2CreERT2EYFP+ cells. We
pulsed Tlr2CreERT2Rosa26EYFP embryos from E7.75 to E10.5 with
a single dose of 4-OHT and assessed the phenotype of
Tlr2CreERT2EYFP+ cells at E11.5 in YS and FL by ﬂow cytometry
(FCM) (Fig. 4f, g). When pulsed between E7.75 and E9.5,
Tlr2CreERT2EYFP+ cells at their c-kit+ stage colonized FL where
they retained mostly a c-kit+ phenotype with only a fraction
differentiating to c-kit+CD45+ cells. In YS, Tlr2CreERT2EYFP+
cells differentiated to c-kit+CD45+ and CD45+ cells, a vast
majority of which were F4/80HIGHCD11b+ MFs. In contrast, a
minute CD45+ myeloid population in FL was predominantly F4/
80LOWCD11b+. Importantly, the highest labeling efﬁciency of
E11.5 FL cells was achieved upon labeling from E7.5 to E8.5
(Supplementary Fig. 5f). These results imply that the wave
of E7.5–8.5 Tlr2CreERT2EYFP+ EMP precursors contributed
the most to the pool of hematopoietic cells differentiating in
the FL.
When tracing the fate of cells labeled by Tlr2 at E8.5 at later
stages of development (E12.5–E15.5; Supplementary Fig. 5g), we
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observed that c-kit+ cells gradually disappeared from YS as the
number of myeloid and erythroid cells increased. Starting from
E12.5, the number of labeled erythroid cells in FL increased at the
expense of c-kit+ as well as c-kit+CD45+ progenitors, attesting
for the relocalization of the main site of erythropoiesis from
YS to FL.
Tlr2-driven production of diphtheria toxin efﬁciently deletes
EMPs. To determine the phenotype of embryos that lack TLR2+
cells, we employed a Rosa26DTA reporter strain whereby the
activation of the diphtheria toxin (DTA) module causes cell death
(Fig. 5a). Depletion of TLR2+ cells from E11.5 Tlr2CreRosa26DTA
embryos was highly efﬁcient (Fig. 5a, b, left scatterplot; Supple-
mentary Fig. 6a) and caused lethality before E13.5 (Supplemen-
tary Fig. 6b). At E11.5, the absence of TLR2+ cells translated into
a signiﬁcant decrease of myeloid cells as well as their progenitors
in the YS, head, and caudal part of the embryo (Fig. 5a, b). By
E11.5, c-kit+CD45+ progenitors had vanished in all compart-
ments. Consistent with Tlr2 activity in tissue MFs, microglia were
also efﬁciently depleted (Supplementary Fig. 6c). While the
depletion of TLR2+ cells did not affect the counts of EryPs in
E12.5 peripheral blood, it caused severe defects in FL deﬁnitive
hematopoiesis (Supplementary Fig. 6d, e). E12.5 Tlr2CreR-
osa26DTA livers were pale and had reduced cellularity as com-
pared with livers of wt animals. In addition, EMPs and MFs were
virtually absent and the counts of Early E, as well as erythroid
cells were severely decreased (Supplementary Fig. 6e). Thus, while
primitive erythropoiesis remained intact, EMP-derived ery-
thropoiesis was severely affected upon depletion of TLR2+ cells. It
is of note, that even though Tlr2 locus is activated also in some
non-hematopoietic cells, their numbers were not affected by Tlr2
driven depletion, strongly advocating that lethality was caused by
aberrant EMP-dependent hematopoiesis. Thus, the Tlr2 locus is
activated in the earliest YS-derived c-kit+ precursors of EMPs
which in Tlr2CreRosa26DTA embryos, due to DTA toxicity, largely
fail to mature to the erythro-myeloid progenitor stage and
beyond.
Tlr2 locus is active in hematopoietic clusters emerging from
the mouse aorta. Analysis of adult Tlr2CreRosa26EYFP mice BM
showed that the Tlr2 locus is active in phenotypical LT-HSC
(Supplementary Fig. 3d). To determine whether it is also active in
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HSCs during embryonic development, we imaged the aortic
sections of E10.5 Tlr2CreRosa26EYFP embryos (28–34sp) where
intra-aortic hematopoietic clusters (IAHCs) emerged from the
CD31+ endothelium10,37. In addition to endothelial cells at the
lining of the aorta, IAHCs were also labeled (Fig. 6a). Moreover,
in the aortic parts of these embryos, pre-HSCs38 showed the most
efﬁcient labeling among all populations tested (98% ± 4.0 SD) as
opposed to endothelial cells which were only partially labeled
(40% ± 7.5 SD) (Fig. 6b; Supplementary Fig. 7a). This suggests
that activation of the Tlr2 locus in blood cells occurred at the time
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of HSCs speciﬁcation. In addition, the emergence of IAHCs was
disrupted in Tlr2CreRosa26DTA embryos (Fig. 6c) where pre-HSCs
were absent (Fig. 6d; Supplementary 7b).
E8.5 HSC progenitors with an active Tlr2 locus contribute to
adult hematopoiesis. To address if early Tlr2CreERT2EYFP+
progenitors contribute to adult hematopoiesis, we pulsed
Tlr2CreERT2Rosa26EYFP embryos from E6.75 to E10.5 with a single
dose of 4-OHT and monitored Tlr2CreERT2EYFP+ cells in the
peripheral blood (PB) of animals until 16 weeks of age (Fig. 7a).
While the ﬁrst time point of PB labeling of all three main
hematopoietic lineages occurred at ~E7.75–8.0, it persisted for
only the ﬁrst 4 weeks of life, thus targeting EMPs and LMPs
(Fig. 7a). The highest efﬁciency of labeling was achieved when
pulsed at E8.5 (Fig. 7a), whereby Tlr2CreERT2EYFP+ cells con-
tributed to all three main hematopoietic lineages in all hemato-
poietic tissues tested at 16 weeks of age (Fig. 7b; Supplementary
Fig. 8a). When the E15.5 FL of these mice were analyzed, ST-
HSC, multipotent progenitors (MPP), and LT-HSCs were labeled
at the highest frequencies (Fig. 7c). Moreover, E8.5 Tlr2-labeled
Lin– BM cells (n= 8) engrafted primary, lethally irradiated reci-
pients for more than 16 weeks (Fig. 7d; Supplementary Fig. 8b)
Then, lineage-depleted Tlr2CreERT2EYFP+ sorted cells isolated
from BM of primary recipients 16-weeks after transplantation
engrafted secondary adult lethally irradiated recipients giving rise
to all three hematopoietic lineages (Fig. 7d; Supplementary
Fig. 8c) demonstrating their ability to self-renew. These data
imply that Tlr2CreERT2EYFP+cells that give rise to HSCs activated
their Tlr2 locus as early as E8.5. This stage so far represents one of
the earliest known events in the HSC speciﬁcation process.
Discussion
Our study has established that the expression of TLR2 on c-kit+
cells allows for the discrimination of emerging multi-lineage
precursors of EMPs from c-kit+ progenitors of the primitive
erythroid wave, both of which are present in E7.5 embryos.
Notably, phenotypic analysis and clonogenic assay demonstrated
that only TLR2+c-kit+ but not TLR2–c-kit+ cells are able to
mature to CD45+ hematopoietic cells and produce mixed colo-
nies. The data from Tlr2CreERT2Rosa26EYFP and Tlr2CreR-
osa26EYFP embryos conﬁrmed that the Tlr2 locus in
hematopoietic precursors is activated at ∼E7.5, which is followed
at E8.5 by the emergence of the ﬁrst EYFP-labeled c-kit+ cells
exhibiting essential EMP characteristics. Importantly, genetic
ablation of these progenitors with active Tlr2 locus left the pri-
mitive erythropoiesis intact. This data is in agreement with pre-
viously reported labeling of EMPs by 4-OHT at E7.75 in
Csf1rMeriCreMer embryos22. Indeed, Tlr2 expressing cells were
enriched in the hematopoietic progenitor cluster identiﬁed by
single cell proﬁling of E7.75 cells39. Consistent with the co-
expression of TLR2 on c-kit+ progenitors shown in this study, the
emergence of the earliest pre-HSCs at E8.5 can be visualized by
lineage tracing using both Tlr2- and c-Kit-based reporter
systems24.
The co-expression of TLR2 and c-kit markers as the earliest
signature of emerging EMPs precursors aids to clarify the
sequence and developmental relationships among early hemato-
poietic waves. Since it has been assumed that the primitive and
EMP waves emerge successively at E7.5 and E8.5, respectively40,
preferential labeling of brain microglia over other tissue resident
MFs at E7.5 using Runx1, Tie2, or c-Kit drivers22–24, has led some
to propose that they originated from the primitive wave. Our data
supports an alternative view that, due to their appearance at E7.5,
c-kit+TLR2+ precursors of EMPs could represent the main
source of progenitors for brain microglia, fetal, and adult tissue-
resident MFs as well as fetal deﬁnitive erythrocytes4,41. The brain
vasculature develops early, hence it becomes a primary sink of
migrating precursors of EMPs42. In line with previous reports, we
also showed that EMPs, the precursors of which expressed TLR2
between E7.75 and E8.5, were the main source of cells seeding FL,
where they expanded and differentiated mostly to monocyte-like
F4/80LOWCD11b+ myeloid cells, whereas beyond FL they pre-
ferentially produced F4/80HIGHCD11b+ tissue resident MFs6,22.
Thus, while our data advocates a shared endothelial origin and an
overlapping expression pattern of Runx1, CD41, Tie2, and CD31
between E7.5 progenitors of the primitive and EMP waves, it is
the acquisition of TLR2 and the enhanced expression of CD41,
Tie2 and CD31 on the background of c-kit that marks the
initiation of the ontogenetic program which endows early pro-
genitors with the acquisition of multi-lineage erythro-myeloid
potential. Endogenous labeling of cells with an active Tlr2 locus
showed that EryPs were labeled only at a very low efﬁciency,
hardly overcoming the background labeling level, suggesting that
the activation of the Tlr2 locus occurs predominantly and most
robustly in emerging EMPs and their progeny. Thus, the con-
tribution of Tlr2-labeled EryPs to their total pool is negligible as is
the effect of their depletion on early embryonic erythropoiesis. At
E8.5, ~60–90% of EMPs were labeled by Tlr2 activation, followed
by progenitors of MFs, Mks, and Eryps.
Functionally analogous to the situation in adult BM29, sti-
mulation of E8.5 TLR2+c-kit+ progenitors and E8.5
Tlr2CreEYFP+c-kit+Lin– cells by the TLR2 ligand enhanced
their proliferation rate as well as differentiation to myeloid cells
in a MyD88-dependent manner. However, as TLR2+ embryonic
progenitors were still able to proliferate and differentiate into
myeloid cells regardless of ligand stimulation, TLR2-generated
signals seemed to be dispensable for normal embryonic mye-
lopoiesis under noninﬂammatory conditions. Presently, no
evidence for the impaired development of myeloid cells at
steady-state in Tlr2–/– or MyD88–/– mice has been
reported43,44. Thus, the early activation of the Tlr2 locus and its
dispensability for the process of embryonic development, makes
Tlr2 regulatory elements a suitable target for the generation of
experimental models for fate mapping of the earliest steps in
embryonic hematopoiesis.
Fig. 6 E10.5 aortic pre-HSC activate their Tlr2 locus. a Cryosections of E10.5 (28–34sp) dorsal aortae with intra-aortic hematopoietic clusters (IAHCs) were
analyzed from Tlr2CreRosa26EYFP embryos by staining for EYFP (green), c-kit (red) and CD31 (white). A representative image is shown (n= 5 independent
experiments with 1–2 embryos per experiment). b Aortic regions were dissected from E10.5 Tlr2CreRosa26EYFP embryos (28–34sp), and hematopoietic
populations as well as endothelial cells were analyzed for their labeling efﬁciency by FCM. The gating strategy for each indicated subset adopted from
ref., 38 is shown in Supplementary Fig 7a. c Sections of E10.5 (28–34sp) aortae were taken from Tlr2CreRosa26DTA (left panel) and Tlr2wtRosa26DTA (middle
and right panels) embryos and stained for c-kit (green), CD31 (red), and CD45 (white) to identify IAHCs. Scale bar represents 50 µm. A representative
image is shown (n= 5 independent experiments with 1–2 embryos of each genotype per experiment). d Aortic regions were disected from E10.5
Tlr2wtRosa26DTA (black dots) and Tlr2CreRosa26DTA (red dots) embryos (28–34sp). Hematopoietic populations as well as endothelial cells were analyzed for
their frequencies by FCM (mean ± SEM; n= 4; *p < 0.05; paired, two-tailed t test). Gating strategy is shown in Supplementary Fig. 7b. Source data are
provided as a Source Data ﬁle
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At E8.5, in Tlr2CreERT2Rosa26EYFP embryos, in addition to
EMPs, HSC progenitors were labeled at the highest efﬁciency,
which correlates with the expression of Tlrs on hematopoietic
cluster cells in Ly6aGFP transgenic animals32. EMPs and HSCs
originate from distinct populations of endothelial cells17, yet the
onset of their Tlr2 promoter activity at E8.5 seems to be
ontogenetically synchronized. The indication that the activation
of the inﬂammatory expression program occurs during EHT32,45,
together with our ﬁnding that TLR2 stimulation of the earliest
TLR2+c-kit+ YS precursors as well as BM-derived HSCs29 aug-
mented their myeloid fate, suggests that the mechanism of TLR-
driven hematopoiesis under inﬂammatory conditions is not only
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operational in adult but also in embryonic hematopoietic pro-
genitors. Indeed, a number of studies has reported that proin-
ﬂammatory cytokines are important players in HSCs speciﬁcation
in the mouse and zebraﬁsh32,46,47. In this scenario, TLR expres-
sion represents one of the oldest, evolutionary conserved and
ontogenetically synchronized genetic programs activated during
hematopoietic speciﬁcation.
Taken together, the Tlr expression program is not only
operational in embryonic and adult hematopoietic progenitors,
endothelial cells, and MFs regardless of their origin33 but it is
initiated in the earliest YS-derived deﬁnitive hematopoietic pro-
genitors as well as ancestors of HSCs.
Methods
Animals. CD1 and C57Bl/6J mice were maintained at the animal facility of the
Institute of Molecular Genetics in Prague (IMG). pCAGEGFPMos3 mice expres-
sing EGFP under the control of the Actb promoter, here referred to as ActbEGFP
mice were generated and provided by Petr Svoboda48. MyD88–/– mice (B6.129P2
(SJL)-Myd88tm1.1Defr/J) and Rosa26DTA (B6.129P2-Gt(ROSA)26Sortm1(DTA)Lky/J)
reporter mice were purchased from The Jackson Laboratory. Rosa26tdTomato
(B6;129S6-Gt(ROSA)26Sortm14(CAG-tdTomato) Hze/J) and Rosa26EYFP
(B6.129 × 1-Gt(ROSA)26Sortm1(EYFP)Cos/J) reporter mice were provided by V.
Korinek. Tlr2Cre and Tlr2CreERT2 transgenic mice were generated by inserting Cre
and CreERT2 cassettes, respectively, under the control of the Tlr2 promoter by BAC
recombineering49. Murine BAC clone RP23-455F23 encompassing Tlr2 gene with
extensive upstream (46 kb) and downstream (123 kb) sequences was obtained from
the BAC resource depository at CHORI. By homologous recombination, the open-
reading frame of Tlr2 exon 3 was substituted with Cre and CreERT2 cDNA,
respectively. BAC DNA for pronuclear injection was prepared using the QIAGEN
Large-Construct Kit and analyzed by pulsed-ﬁeld gel electrophoresis. The pro-
nuclear injection of the construct (1 ng/µl) into mouse zygotes was carried out at
the Transgenic Unit of IMG. Founders were identiﬁed by PCR ampliﬁcation of tail
DNA with speciﬁc primers for Tlr2Cre transgenic and wt alleles: Tlr2F (common)
5′-AGCCATAGGCCACATCTAGT-3′, Tlr2CreR 5′-GTATGCTCAGAAAACGC
CTG-3′ (470b), and Tlr2wtR 5′-AAAAAGCGATGTTACCCC-3′ (784b) and
backcrossed to C57BL/6 mice. All experiments included littermate controls with
the minimum sample size of three animals. Embryonic development was estimated
by considering the day of vaginal plug formation as embryonic day 0.5 (E0.5) and
staged using standard criteria50. To obtain E7.5 embryos, we used E7.5 time
pregnant females and strictly selected only those embryos that were at the neural
plate stage (NPS) with no visible signs of alantoic bud or structure, with an
apparent cranial limit furrow and pointy node (i.e. E7.25–7.5, on rare occassion up
to 7.75). All embryos, which were older than those without the “alantois bud stage”
of NPS, were excluded from CFU assays experiments. In various other experiments,
somite pairs were counted to determine embryo age more accurately. All experi-
ments were approved by the ethical committee of the IMG.
Cell suspension preparation. Time pregnant females were killed by cervical
dislocation, and embryos were dissected from uteri. E7.5–8.5 embryos were care-
fully stripped of maternal decidua, Reichart’s membrane and ectoplacental cone.
For ﬂow cytometry (FCM) and qPCR analyses and cell sorting, cells from E7.5-E8.5
dissected embryos were pooled from one litter. E9.5–12.5 embryos were separated
from extraembryonic membranes (YS and amnion), and single embryos were
analyzed unless stated otherwise. Embryos were washed in Hank’s balanced saline
solution (HBSS) and dissociated using 1 mg/ml dispase (Invitrogen) in HBSS for
10 min at 37 °C with occasional gentle pipetting. The reaction was stopped by
washing in 2% FCS in HBSS. Embryonic suspensions were then passed through a
50-μm cell strainer. Peripheral blood of adult animals was collected from the facial
vein into PBS EDTA solution, and red blood cells were lysed in ACK solution.
Flow cytometry and cell sorting. After Fc receptor blocking (in experiments
where FcRγ was not stained) by rat anti mouse FcRγ antibody (2.4G2; Biolegend),
single-cell suspensions were stained with conjugated monoclonal antibodies for 30
min on ice. Where appropriate, cells were further incubated with streptavidin
conjugates for 20 min. The full list of antibodies and secondary reagents used can
be found in the reporting summary. Fluorescence data were acquired using LSRII
ﬂow cytometer (BD Biosciences). FCM analysis was performed using FlowJo
software (FlowJo, LCC). Cell debris and dead cells were excluded from the analysis
based on scatter signals and viability dye ﬂuorescence (Hoechst 33258 (Sigma-
Aldrich), Sytox-blue, Fixable viability dye eFluor780 (Thermo Fisher Scientiﬁc)).
Cell sorting was performed with an Inﬂux cell sorter (BD Biosciences). For t-SNE
and hierarchical clustering analysis, raw or pre-gated FCS3.0 ﬁles were exported
from acquisition software and imported into R environment where all subsequent
analyses were carried out51.
t-SNE. For dimensionality reduction and subsequent population choices across all
measured parameters, we used Barnes-Hut implementation of t-Distributed Sto-
chastic Neighbour Embedding (t-SNE)52. In Fig. S1H, a tSNE map was built using
a tSNE plugin in FlowJo software (FlowJo, LCC).
Hierarchical clustering analysis for ﬂow cytometry. Agglomerative unsu-
pervised Hierarchical clustering analysis (HCA) was performed using Mahalanobis
distance measure and Mahalanobis-based custom linkage53. From the resulting
hierarchy, the clusters (cell populations) were selected based on dendrogram
topology and a matrix of parameters scatterplots.
Gene expression analysis. The total RNA from whole embryos or sorted cells was
isolated using a RNeasy Plus Micro Kit (Qiagen) and was reverse transcribed using
Premium RevertAid (Fermentas) and random hexamers (Fermentas). Quantitative
RT-PCR (qPCR) was performed using the LightCycler 480 SYBR Green I Master
mix on a LightCycler 480 instrument (Roche). Each sample was tested in triplicate.
The relative amounts of mRNA were calculated using LightCycler 480 1.5 software
with Casc3 or Gapdh mRNA levels as a reference gene. Primers were designed
using UPL software (Roche). Intron-spanning assays were used when possible.
Primer efﬁciencies were calculated using LightCycler 480 1.5 software. Primer
sequences are listed in Supplementary Table 1. Data were analyzed using Prism
5.03 software (GraphPad). The expression level of different Tlrs and their adaptors
highlighted in Supplementary Fig. 1a precluded the effect of primer efﬁciency
factor.
Tracking cells of maternal and embryonic origin. To follow the cells of
embryonic origin, we crossed wt CD1 females with ActbEGFP males. Only EGFP+
embryos were included in subsequent analysis. Due to paternal inheritance, all
ActbEGFP+ cells were considered to be of embryonic origin (Supplementary Fig. 1b,
left panel). To follow maternal cells, ActbEGFP/wt females were crossed with wt CD1
males. Maternally derived ActbEGFP+ cells were analyzed in wt embryos that did
not inherit the maternal EGFP allele (~50%) (Supplementary Fig. 1b, right panel).
Fig. 7 Progenitors with active Tlr2 locus labeled at E8.5 contribute to adult hematopoiesis. a Tlr2CreERT2Rosa26EYFP embryos pulsed with a single dose of 4-
OHT between E6.75-E10.5 were monitored postpartum for the presence of Tlr2CreERT2EYFP+ cells in their peripheral blood (PB) up to 16 weeks of age
(mean ± SEM; n= 9–25; * indicates short-term hematopoietic potential which persisted for only the ﬁrst 4 weeks of life. b Percentage of Tlr2CreERT2EYFP+
cells, labeled at E8.5, and their contribution to the main CD45+ lineages in different hematopoietic organs is shown (mean ± SEM; n= 5–7; see gating
strategy in Supplementary Fig. 8a). c Tlr2CreERT2Rosa26EYFP embryos were pulsed with a single dose of 4-OHT at E8.5, and labeling efﬁciency of indicated
hematopoietic populations was analyzed in E15.5 FL by FCM. LT-HSC gate is shown as an example. d Tlr2CreERT2Rosa26EYFP embryos were pulsed with a
single dose of 4-OHT at E8.5. At 16 weeks of age, Lin-depleted BM (CD45.2) (w16 Lin– BM; see Supplementary Fig. 8b) was transferred to lethally
irradiated primary recipients (CD45.1/2) along with support BM cells (0.5 × 106 CD45.1), and the level of Tlr2CreERT2EYFP+ cells was monitored in PB of
primary recipients until week 16 (upper left panel). The percentage of Tlr2CreERT2EYFP+ cells, their organ distribution and fate in primary recipients is shown
(mean ± SEM; n= 6). Bar graphs show the reconstitution success and fate of Tlr2CreERT2EYFP+ cells in primary recipients (A–C’) of BM from eight
individual donors (#1–8). Sorted Tlr2CreERT2EYFP+ cells (see Supplementary Fig. 8c) from Lin-depleted BM of 16-week old primary recipients were
transferred to secondary, lethally irradiated recipients (CD45.1/2) along with support BM cells (0.5 × 106, CD45.1) and the frequency of Tlr2CreERT2EYFP+
cells in PB was monitored until week 16 (the outcome of BMT from one primary recipient (donor T) is shown (secondary recipients, upper row, left panel).
The percentage of Tlr2CreERT2EYFP+ cells, their organ distribution and fate in secondary recipients is shown (mean ± SEM; n= 8). Bar graphs on the bottom
indicate the reconstitution success and fate of Tlr2CreERT2EYFP+ cells in secondary recipients (1´−34´) of BM from four primary recipients. Source data are
provided as a Source Data ﬁle
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In vitro assays. Distinct subpopulations of E7.5 or E8.5 embryonic ActbEGFP+
cells were sorted based on their TLR2, c-kit, and CD45 surface expression, plated
on a semi-conﬂuent layer of OP-9 cells54 (gift from J.C. Zuniga-Pﬂucker) or ST-2
cells55 (gift from L. Klein) and cultured in RPMI containing 5% FCS (Sigma-
Aldrich). E7.5 sorted cells were supplemented with recombinant cytokines IL-3 (1
ng/ml), SCF (50 ng/ml) GM-CSF (3 ng/ml), and M-CSF (10 ng/ml) (Biolegend). A
thousand cells from each E8.5 sorted ActbEGFP+ population labeled with Cell
Proliferation Dye eFluor® 670 (eBioscience) were co-cultured with OP-9 cells in the
presence or absence of 1 μg/ml Pam3CSK4 (Invivogen) for 72 h. The total number
of surviving ActbEGFP+ cells were normalized to 10,000 events obtained by FCM
analysis. E8.5 Tlr2CreEYFP+ Lin– cells were sorted, stained with Cell Proliferation
Dye eFluor® 670 (eBioscience) and cultured in the presence or absence of
Pam3CSK4 (1 µg/ml) on ST-2 stroma. The proliferation history of embryonic cells
was determined by the dilution of Cell Proliferation Dye® eFluor 670 according to
the manufacturer’s instructions.
Colony-forming cell assay. Sorted E7.5 or E8.5 cells were plated on methylcel-
lulose medium M3434 GF (Stem Cell Technologies) according to the manu-
facturer’s instructions. Cultures were maintained at 37 °C in humidiﬁed air with 5%
CO2. Hematopoietic colonies were scored at days 5 and 12. For EryP clonogenic
assays, M3434 was supplemented with 3U/ml erythropoietin and 10% FCS.
Microscopic images were acquired using Nikon Diaphot 300 equipped with 10 × /
0.25 or Plan 20 × /0.4 objectives.
Single-colony qPCR. Individual erythroid colonies were imaged and individually
transferred to 5 μl of lysis buffer (0.1 % BSA in RNAse free water supplemented
with RNAse inhibitors) and instantly frozen on dry ice. Cell lysate was then used
for reverse transciption (Superscript III RT, Thermo Fisher Scientiﬁc). qPCR was
performed using the LightCycler 480 SYBR Green I Master mix in a LightCycler
480 instrument (Roche).
Whole embryo ex vivo imaging. Tlr2CreEYFP+ cells in E8.5-E10.5
Rosa26EYFPTlr2Cre embryos were imaged with a Nikon AZ-100 confocal micro-
scope equipped with a ×4 objective. Images of E7.5 ActbEGFP embryos and E11.5
Tlr2wtRosa26DTA and Tlr2CreRosa26DTA embryos were acquired using a Olympus
SZX9 StereoZoom microscope equipped with a DF PLAPO 1xPF objective and a
DP72 digital camera.
Whole mount embryo immunohistochemistry and imaging. E7.5 embryos were
dissected from decidua, washed several times in ice-cold PBS, ﬁxed overnight in
PHEM ﬁxative (80mM PIPES, 5mM EGTA, 1mM MgCl2, 25mM HEPES at pH of
7.2, 3.7% formaldehyde, puriﬁed 0.1% Triton X-100) at 4 °C, and then rinsed three
times in PBS. Embryos were blocked in PBS supplemented with 10% goat serum for 1
h. The primary antibody, puriﬁed rat anti-mouse TLR2 (clone 6C2, eBioscience) was
added at a ﬁnal concentration of 5 μg/ml for overnight at 4 °C and developed with the
secondary goat anti-rat IgG labeled with Alexa 488. The isotype control antibody
produced no speciﬁc staining. Embryos were then embedded with Vectashield
mounting medium with 4‘,6-diamino-2-phentlindole (DAPI) (Vector Laboratories)
and prepared for scanning. Signals were visualized and digital images were obtained
using a Zeiss LSM 780 equipped with two photon, argon and helium–neon lasers. For
3D image, individual confocal planes (25–30 planes in 1–2 μm intervals) were pro-
jected to generate a single stacked 3D-reconstructed image using Imaris 7.3 (Bitplane).
Preparation of aortic regions for imaging and FCM analysis. Caudal parts of
E10.5 embryos including somites were cut between forelimbs and hindlimbs. These
parts and the aortae were gently ﬂushed with HBSS using a syringe to remove
blood cells. Aortic regions were either washed and ﬁxed in 3.7% PFA in PBS for
subsequent imaging or digested with dispase for FCM analysis.
Immunoﬂuorescence of embryonic sections and imaging. Embryos were ﬁxed
with 3.7% PFA in PBS overnight at 4 °C, washed in PBS, transferred to 30% sucrose
and mounted in OCT for freezing and sectioning. Sections (8–10-μm thick) were
postﬁxed in 3.7% PFA in PBS, permeabilized in methanol for 10 min at −20 oC
(except for phalloidin staining), then blocked in 5% BSA in 1% BSA 0.1% Triton-
X100 (PBT) and stained with antibodies in 1% BSA PBT. The complete list of
antibodies and secondary reagents used can be found in the NR reporting sum-
mary. The coverslips were mounted using Vectashield containing DAPI (Vector
Laboratories). Sections were imaged with Leica DM6000 epiﬂuorescence micro-
scope equipped with HCX PL APO 10.0 × 0.40, HCX PL APO 20 × 0.7 and HCX
PL APO 40 × 0.75 objectives or with a Dragonﬂy 503 spinning disc confocal
microscope and/or equipped with a HC PL APO 20 × / 0.75 IMM objective.
Continuous labeling of Tlr2 progenitors. For fate-mapping analysis of Tlr2
precursors, Rosa26EYFP or Rosa26tdTomato females were crossed with Tlr2Cre males.
The indicated tissues from embryos and adult F1 mice were analyzed by FCM and
imunoﬂuorescence.
Pulse labeling of Tlr2 progenitors. For genetic cell labeling of embryonic cells, we
crossed Rosa26EYFP reporter mice with tamoxifen-inducible Tlr2CreERT2 mice.
Recombination was induced by a single i.p. injection of 1.5 mg 4-hydroxytamoxifen
(4-OHT; H6278; Sigma) into pregnant females from E6.75 to E10.5. When 4-OHT
was administered after E9.5, the delivery was assisted by C-section at E20.5 and
pups were transferred to foster mothers.
Embryonic lethality assay. Rosa26DTA/DTA females were crossed with Tlr2Cre/wt
males to obtain litters with equal numbers of wt (Tlr2wt/wtRosa26DTA/wt) and
tg (Tlr2Cre/wtRosa26DTA/wt) genotypes, if no lethality occurs. Litters were scored
for phenotype (normal growth, growth retardation, resorbtions) from E9.5
to E13.5.
Analysis of embryonic peripheral blood. E11.5- E12.5 embryos were carefully
removed from decidua and placenta, and washed three times in PBS. Upon placing
intact embryos in individual wells containg 0.02% EDTA in PBS, umbilical vessels
were cut and embryos were bled out. Cell suspensions were collected and spun for
subsequent analyses (counting and FCM analysis).
May Grunwald Giemsa staining of frozen sections and blood smears. In total,
8-μm thin cryosections prepared from E12.5 FLs, and smears from PB were stained
with May Grunwald Giemsa (MGG) stain (Diapath) according to the manu-
facturer’s intructions and imaged with a Leica DM6000 microscope equipped with
a 40x objective. Images were processed in ImageJ.
Transplantation of Tlr2-labeled BM cells into lethally irradiated mice.
Rosa26EYFPTlr2CreERT2 embryos were pulsed with 4-OHT at E8.5. After 16 weeks,
lineage-depleted BM (CD45.2) was transferred to lethally irradiated (2 × 7.5 Gy
delivered by orthovoltage X-ray instrument T-200; Wolf-Medizintechnik) reci-
pients (CD45.1/2) along with support (0.5 × 106 CD45.1) BM cells. Recipient mice
were maintained on antibiotic water (gentamycin, 1 mg/ml) for 10 days. Sixteen
weeks after primary cell transfer, BM was isolated and after lineage depletion,
Tlr2EYFP+ cells were sorted and transferred to secondary lethally irradiated
recipients (CD45.1/2) along with support (0.5 × 106 CD45.1) BM cells. The per-
centage of EYFP labeled cells and their contribution to CD45+ hematopoietic
lineages in different organs was determined 16 weeks after induction or BM
transfer, respectively.
Whole-body imaging. The total ﬂuorescence of tdTomato in adult Rosa26tdTomato
Tlr2Cre animals was acquired by Xtreme whole body imager (Bruker). Fluorescence
spectra of excitation wavelengths from 420 nm to 540 nm with 580–629 nm
emission ﬁlter were measured. Multispectral analyzer software (Bruker) was used to
distinguish non-speciﬁc body autoﬂuorescence from the speciﬁc tdTomato signal.
Quantiﬁcation and statistical analysis. Data was statistically analyzed using
Prism 5.03 software (GraphPad). The statistical tests used are indicated in the
corresponding Figure legends.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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